• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

樟柳碱衍生的毒蕈碱受体拮抗剂的设计、合成及构效关系研究

Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists.

作者信息

Doller D, Chackalamannil S, Czarniecki M, McQuade R, Ruperto V

机构信息

Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.

出版信息

Bioorg Med Chem Lett. 1999 Mar 22;9(6):901-6. doi: 10.1016/s0960-894x(99)00101-8.

DOI:10.1016/s0960-894x(99)00101-8
PMID:10206558
Abstract

A parallel synthesis of racemic himbacine analogs was carried out by N-alkylation of various commercially available cyclic amine derivatives with the alkylating agent 4 which bears the tricyclic unit of himbacine. Several of these analogs have potency comparable to that of himbacine, albeit lacking the desired selectivity. Structure-activity relationship studies support the existence of a hydrophobic pocket in the receptor where the piperidine ring of dihydrohimbacine binds.

摘要

通过将各种市售的环状胺衍生物与带有海巴辛三环单元的烷基化剂4进行N-烷基化反应,对外消旋海巴辛类似物进行了平行合成。这些类似物中有几种具有与海巴辛相当的效力,尽管缺乏所需的选择性。构效关系研究支持受体中存在一个疏水口袋,二氢海巴辛的哌啶环与之结合。

相似文献

1
Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists.樟柳碱衍生的毒蕈碱受体拮抗剂的设计、合成及构效关系研究
Bioorg Med Chem Lett. 1999 Mar 22;9(6):901-6. doi: 10.1016/s0960-894x(99)00101-8.
2
Himbacine analogs as muscarinic receptor antagonists--effects of tether and heterocyclic variations.作为毒蕈碱受体拮抗剂的海巴辛类似物——连接链和杂环变化的影响
Bioorg Med Chem Lett. 2004 Aug 2;14(15):3967-70. doi: 10.1016/j.bmcl.2004.05.047.
3
Synthesis and muscarinic M2 subtype antagonistic activity of unnatural ent-himbacine and an enantiomeric pair of (2'S,6'R)-diepihimbacine.非天然对映贝壳杉烯碱及(2'S,6'R)-二表贝壳杉烯碱对映体对的合成及其毒蕈碱M2亚型拮抗活性
Bioorg Med Chem Lett. 2002 Oct 21;12(20):2871-3. doi: 10.1016/s0960-894x(02)00566-8.
4
A novel short convergent entry into himbacine derivatives.一种新型的通向himbacine衍生物的短收敛合成路径。
Org Lett. 2002 May 2;4(9):1579-82. doi: 10.1021/ol025801g.
5
Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.樟柳碱衍生的毒蕈碱受体拮抗剂的合成及亲和力研究
Bioorg Med Chem Lett. 2002 Aug 5;12(15):1909-12. doi: 10.1016/s0960-894x(02)00315-3.
6
Synthetic studies on himbacine, a potent antagonist of the muscarinic M2 subtype receptor. Part 2: synthesis and muscarinic M2 subtype antagonistic activity of the novel himbacine congeners modified at the C-3 position of lactone moiety.毒蕈碱M2亚型受体强效拮抗剂辛巴碱的合成研究。第2部分:在内酯部分C-3位修饰的新型辛巴碱类似物的合成及毒蕈碱M2亚型拮抗活性
Bioorg Med Chem. 2003 Apr 3;11(7):1169-86. doi: 10.1016/s0968-0896(02)00665-x.
7
Structure-activity relationships of some Galbulimima alkaloids related to himbacine.一些与himbacine相关的加布力米马生物碱的构效关系。
Eur J Pharmacol. 1990 Jun 21;182(1):131-6. doi: 10.1016/0014-2999(90)90501-v.
8
Synthesis and muscarinic M(2) subtype antagonistic activity of enantiomeric pairs of 3-demethylhimbacine (3-norhimbacine) and its C(4)-epimer.3-去甲基喜巴辛(3-去甲喜巴辛)及其C(4) -差向异构体对映体对的合成与毒蕈碱M(2)亚型拮抗活性
Bioorg Med Chem Lett. 2002 Nov 18;12(22):3271-3. doi: 10.1016/s0960-894x(02)00695-9.
9
Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor.二苯基亚砜作为毒蕈碱M2受体的选择性拮抗剂。
Bioorg Med Chem Lett. 2000 Oct 16;10(20):2255-7. doi: 10.1016/s0960-894x(00)00438-8.
10
Himbacine derived thrombin receptor (PAR-1) antagonists: structure-activity relationship of the lactone ring.源自辛巴生的凝血酶受体(PAR-1)拮抗剂:内酯环的构效关系
Bioorg Med Chem Lett. 2006 Sep 15;16(18):4969-72. doi: 10.1016/j.bmcl.2006.06.042. Epub 2006 Jul 7.

引用本文的文献

1
Targeting PAR1 activation in JAK2V617F-driven philadelphia-negative myeloproliferative neoplasms: Unraveling its role in thrombosis and disease progression.靶向JAK2V617F驱动的费城阴性骨髓增殖性肿瘤中的PAR1激活:揭示其在血栓形成和疾病进展中的作用
Neoplasia. 2025 May;63:101153. doi: 10.1016/j.neo.2025.101153. Epub 2025 Mar 14.
2
Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction: role of vorapaxar.降低心肌梗死病史患者血栓形成事件的辅助治疗:沃拉帕沙的作用。
Drug Des Devel Ther. 2015 Jul 22;9:3801-9. doi: 10.2147/DDDT.S68391. eCollection 2015.
3
Vorapaxar: a review of its use in the long-term secondary prevention of atherothrombotic events.
沃拉帕沙:用于动脉粥样血栓事件二级预防的长期治疗。
Drugs. 2015 May;75(7):797-808. doi: 10.1007/s40265-015-0387-9.
4
Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar.急性心肌梗死管理中未满足的需求:新型蛋白酶激活受体-1拮抗剂沃拉帕沙的作用。
Vasc Health Risk Manag. 2014 Apr 3;10:177-88. doi: 10.2147/VHRM.S36045. eCollection 2014.
5
Differential regulation of primary afferent input to spinal cord by muscarinic receptor subtypes delineated using knockout mice.利用基因敲除小鼠描绘毒蕈碱受体亚型对脊髓初级传入输入的差异调节。
J Biol Chem. 2014 May 16;289(20):14321-30. doi: 10.1074/jbc.M114.550384. Epub 2014 Apr 2.
6
Antiplatelet therapy: thrombin receptor antagonists.抗血小板治疗:凝血酶受体拮抗剂。
Br J Clin Pharmacol. 2011 Oct;72(4):658-71. doi: 10.1111/j.1365-2125.2010.03884.x.
7
Dynamic control of glutamatergic synaptic input in the spinal cord by muscarinic receptor subtypes defined using knockout mice.利用基因敲除小鼠鉴定毒蕈碱受体亚型对脊髓中谷氨酸能突触传入的动态调控。
J Biol Chem. 2010 Dec 24;285(52):40427-37. doi: 10.1074/jbc.M110.176966. Epub 2010 Oct 12.
8
Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555.凝血酶受体拮抗剂治疗动脉血栓栓塞症:vorapaxar 和 E-5555 的治疗潜力。
Drugs. 2010 Oct 1;70(14):1771-83. doi: 10.2165/11538060-000000000-00000.
9
Dynamic regulation of glycinergic input to spinal dorsal horn neurones by muscarinic receptor subtypes in rats.毒蕈碱受体亚型对大鼠脊髓背角神经元甘氨酸能输入的动态调节
J Physiol. 2006 Mar 1;571(Pt 2):403-13. doi: 10.1113/jphysiol.2005.102905. Epub 2006 Jan 12.